We show now for the first time that LILRA3 deletion is associated with the malignant disease B-NHL, whose etiology still remains mostly elusive, with only 2 genetic variations in the form of single nucleotide polymorphisms in TNF and IL-10 credited to be genetic risk factors [19], [20]. This evidence concerns the gene IL10 and non-Hodgkin lymphoma.